Institutional Ownership Karyopharm Therapeutics Inc. (KPTI)
This table provides information about the institutional ownership of Karyopharm Therapeutics Inc. (KPTI). We have compiled data on the 97 institutions that hold shares in the stock, with a total of 57.6 Million shares, which have been reported (via 13F filing form) to have a value of $39.2 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
409,510
shares
|
$278,466
0.0% of portfolio
|
Q3 2024
Reduced 9.76%
|
|
Ikarian Capital, LLC
Dallas, TX |
Nov 14, 2024 Q3 2024 |
409,355
shares
|
$278,361
0.06% of portfolio
|
Q1 2024
Added 2.34%
|
|
Acadian Asset Management LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
368,511
shares
|
$250,587
0.0% of portfolio
|
Q3 2024
Added 89.79%
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2024 Q3 2024 |
302,548
shares
|
$205,732
0.0% of portfolio
|
Q3 2024
Reduced 31.78%
|
|
Atom Investors LP
Austin, TX |
Nov 14, 2024 Q3 2024 |
259,824
shares
|
$176,680
0.02% of portfolio
|
Q3 2024
Reduced 0.77%
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Nov 14, 2024 Q3 2024 |
239,500
shares
|
$162,860
0.0% of portfolio
|
Q3 2024
Reduced 9.45%
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
229,668
shares
|
$156,174
0.0% of portfolio
|
Q3 2024
Reduced 73.61%
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
228,941
shares
|
$155,679
0.0% of portfolio
|
Q3 2024
Reduced 23.35%
|
|
Exchange Traded Concepts, LLC
|
Jan 21, 2025 Q4 2024 |
218,791
shares
|
$148,777
0.0% of portfolio
|
Q3 2024
Added 34.91%
|
|
Jane Street Group, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
204,750
shares
|
$139,230
0.0% of portfolio
|
Q3 2024
Reduced 86.79%
|
|
Dafna Capital Management LLC
Los Angeles, CA |
Nov 14, 2024 Q3 2024 |
192,678
shares
|
$131,021
0.04% of portfolio
|
Q4 2022
New holding
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
134,700
shares
|
$91,596
0.0% of portfolio
|
Q3 2024
Added 38.72%
|
|
Ubs Group Ag
|
Nov 14, 2024 Q3 2024 |
134,478
shares
|
$91,445
0.0% of portfolio
|
Q3 2024
Reduced 4.41%
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
134,112
shares
|
$91,196
0.0% of portfolio
|
Q1 2024
Added 14.9%
|
|
Monashee Investment Management LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
132,435
shares
|
$90,055
0.01% of portfolio
|
Q3 2024
New holding
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
123,647
shares
|
$84,079
0.0% of portfolio
|
Q3 2024
Reduced 38.18%
|
|
Citigroup Inc
|
Nov 12, 2024 Q3 2024 |
105,693
shares
|
$71,871
0.0% of portfolio
|
Q3 2024
Reduced 34.77%
|
|
Jefferies Group LLC
New York, NY |
Sep 21, 2023 Q3 2022 |
101,700
shares
|
$69,156
0.01% of portfolio
|
Q3 2022
Added 101600.0%
|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
95,767
shares
|
$65,121
0.0% of portfolio
|
Q3 2024
Reduced 89.03%
|
|
Boothbay Fund Management, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
91,091
shares
|
$61,941
0.0% of portfolio
|
Q1 2024
Added 11.45%
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
85,930
shares
|
$58,432
0.0% of portfolio
|
Q3 2024
Added 519.72%
|
|
Point72 Asia (Singapore) Pte. Ltd.
Singapore, U0 |
Nov 14, 2024 Q3 2024 |
82,446
shares
|
$56,063
0.01% of portfolio
|
Q3 2024
Reduced 50.13%
|
|
Prudential Financial Inc
Newark, NJ |
Nov 13, 2024 Q3 2024 |
74,600
shares
|
$50,728
0.0% of portfolio
|
Q3 2024
New holding
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2024 Q3 2024 |
62,026
shares
|
$42,177
0.0% of portfolio
|
Q3 2024
Reduced 41.74%
|
|
Invesco Ltd.
Atlanta, GA |
Nov 12, 2024 Q3 2024 |
58,152
shares
|
$39,543
0.0% of portfolio
|
Q3 2024
Added 43.55%
|